Friday 11 October 2024

ERJ pick of the week

Pulmonary ischaemia–reperfusion injury accounts for significant morbidity after lung transplant but has no known medical therapies. This study identified a critical role for the natural killer cell co-receptor CD94 in mouse and human lung transplant.

Read the article Submit to the European Respiratory Journal

Tuesday 8 October 2024

Bookshop restocked following ERS Congress

After some ERS Publications titles sold out at the recent ERS Congress in Vienna, the online bookshop has now been fully restocked. The Bookshop was an integral part of this year's ERS Congress World Village, and the ERS Publications team was delighted to see and speak to so many readers, authors and editors, and introduce Congress attendees to recently published titles.

Browse ERS Monographs | Browse ERS Handbooks

Monday 7 October 2024

ERJ Podcast: the ERS Congress 2024

In the latest European Respiratory Journal (ERJ) Podcast, Chief Editor James Chalmers and Deputy Chief Editor Don Sin interview section editor Marc Humbert and Pamela McShane (University of Texas) about articles presented at the ERS Congress.

Listen now | Browse the latest issue of the ERJ

Sunday 6 October 2024

Curbside Consult: latest episode now available

The latest episode of Curbside Consult is now available on the ERS Respiratory Channel. In this episode, hosts Professor Sean Gaine and Dr Emer Kelly discuss sarcoidosis with Professor Carlos Robalo Cordeiro, a past ERS President and Head of the Pneumology Department at Coimbra University Hospital, Portugal.

Watch the episode | Order your copy of the ERS Monograph on Sarcoidosis

Saturday 5 October 2024

Bookshop restocked following ERS Congress

After some ERS Publications titles sold out at the recent ERS Congress in Vienna, the online bookshop has now been fully restocked. The Bookshop was an integral part of this year's ERS Congress World Village, and the ERS Publications team was delighted to see and speak to so many readers, authors and editors, and introduce Congress attendees to recently published titles.

Browse ERS Monographs | Browse ERS Handbooks

Friday 4 October 2024

ERJ Open Research: pick of the week

Two models with improved ability to predict postoperative pulmonary complications in patients scheduled for lung re-section surgery may improve preoperative algorithms, as they stratify risk based on more relevant parameters.

Access the article | Submit your manuscript to ERJ Open Research

Thursday 3 October 2024

ERJ Editors' choice

The Chief Editors of the European Respiratory Journal (ERJ) have selected their highlights from the August issue. Their selection includes original articles on benralizumab for allergic asthma, and low smoking exposure and the development and prognosis of COPD. They also highlight the European Respiratory Society statement on preschool wheezing disorders and a review article on phenotypes in pulmonary hypertension.

Access the Chief Editors' full list 
Visit erj.ersjournals.com to browse the the most highly regarded respiratory journal in Europe

Wednesday 2 October 2024

Lung Health Matters podcast

Episode one of the new Lung Health Matters podcast series is now available. The series looks at the important work the European Respiratory Society (ERS) does to advocate for better respiratory health at EU level and beyond. The first episode is hosted by Professor Barbara Hoffmann (ERS Advocacy Council Chair), who is joined by Professor Monika Gappa (ERS Past President) and Professor Marielle Pijnenburg to discuss the topic of childhood respiratory care.

Listen to the episode | Order your copy of Respiratory Diseases of the Newborn Infant

Tuesday 1 October 2024

ERJ podcast: Titration of anti-IL-5 biologics in severe asthma

As part of its August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marianne Baastrup Soendergaard (Copenhagen University Hospital, Copenhagen, Denmark) about the OPTIMAL study: an open-label randomised controlled trial of titration of anti-interleukin-5 biologic therapy in severe asthma.

Listen to the podcast | Browse the ERJ August issue